











The SMN Tudor SIM-like domain is key to SmD1 and coilin
interactions and to Cajal body biogenesis
Olga Tapia1,*,", Vanesa Lafarga2,{,", Rocio Bengoechea1,§, Ana Palanca1, Miguel Lafarga1,** and
Marı́a T. Berciano1
ABSTRACT
Cajal bodies (CBs) are nuclear organelles involved in the
maturation of spliceosomal small nuclear ribonucleoproteins
(snRNPs). They concentrate coilin, snRNPs and the survival
motor neuron protein (SMN). Dysfunction of CB assembly occurs
in spinal muscular atrophy (SMA). Here, we demonstrate that SMN
is a SUMO1 target that has a small ubiquitin-related modifier
(SUMO)-interacting motif (SIM)-like motif in the Tudor domain. The
expression of SIM-like mutant constructs abolishes the interaction
of SMN with the spliceosomal SmD1 (also known as SNRPD1),
severely decreases SMN–coilin interaction and prevents CB
assembly. Accordingly, the SMN SIM-like-mediated interactions
are important for CB biogenesis and their dysfunction can be
involved in SMA pathophysiology.
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INTRODUCTION
Sumoylation is an important post-translational modification that
regulates protein activity, subcellular localization, stability and
protein–protein interactions (Flotho and Melchior, 2013).
Covalent SUMO modification occurs between the C-terminal
glycine of small ubiquitin-related modifier (SUMO) and a lysine
residue corresponding to a consensus sequence (yKxE/D) in the
target protein (Hay, 2005; Flotho and Melchior, 2013). Some
substrates have also SUMO-interacting motifs (SIMs) that
mediate non-covalent interaction with SUMO1 (Song et al.,
2004; Hecker et al., 2006). SIMs contain a hydrophobic core (V/I-
x-V/I-V/I), generally flanked by acidic and/or phosphorylated
residues, that ensure the affinity for SUMO1 (Kerscher, 2007).
Cajal bodies (CBs) are nuclear organelles discovered by
Ramón y Cajal (Lafarga et al., 2009). They are enriched in coilin,
survival motor neuron protein (SMN) and small nuclear and Cajal
body ribonucleoproteins (snRNPs and scaRNPs) involved in pre-
mRNA processing (Cioce and Lamond, 2005; Nizami et al.,
2010; Machyna et al., 2013). Endogenous SMN conjugates to
Gemin2–Gemin8 and Unrip (also known as STRAP) to form the
SMN complex, which is involved in the biogenesis of
spliceosomal snRNPs. In the cytoplasm, the SMN complex
assembles proteins of the Sm family on the snRNAs to produce
snRNPs that are imported into the nucleus, where they localize
to CBs to culminate their maturation (Fischer et al., 2011).
Disruption of the SMN1 gene produces spinal muscular atrophy
(SMA), a major genetic cause of infantile mortality (Lefebvre
et al., 1997).
Previously, we have shown that a subset of CBs concentrates
active SUMO1 (Navascues et al., 2008). Here, we report that
SMN is a new SUMO1 target. We further show that SMN has a
SIM-like motif in the Tudor domain that regulates its binding
with the SmD1 protein (also known as SNRPD1) of the Sm
complex and coilin. This interaction is essential for controlling
CB assembly and could potentially be involved in SMA
pathophysiology caused by point mutations in the Tudor domain.
RESULTS AND DISCUSSION
SMN is a novel SUMO1 substrate
Our previous results showing the presence of endogenous
SUMO1 in a subset of CBs prompted us to investigate
putative SUMO targets in CBs, particularly in coilin and SMN
proteins. We confirmed in MCF7, 293T and UR61 cells that
some CBs are enriched in SUMO1 (supplementary material Fig.
S1A–C). In UR61 cells, we observed that active SUMO1 only
concentrated in SMN-containing nuclear bodies, but not in
coilin-positive and SMN-negative bodies (supplementary
material Fig. S1D–L). This prompted us to investigate whether
SMN is a SUMO1 target. The localization of SUMO1 in CBs
was also confirmed in MCF7 cells transfected with a GFP-
tagged wild-type (wt) human SMN construct (GFP–SMNwt),
used here for mutagenesis experiments. Thus, co-immunostain-
ing for coilin and either the Sm complex or SUMO1 showed that
GFP–SMNwt was always recruited to canonical CBs, some of
them immunoreactive for SUMO1 (Fig. 1A–H). Next, by co-
immunoprecipitation assays, we demonstrated that both endo-
genous monomeric SMN and GFP–SMNwt interact with
SUMO1 in a covalent manner (Fig. 1I,J). This interaction was
validated with a sumoylation assay (Fig. 1K). Interestingly,
the conjugating enzyme Ubc9 was not detected in CBs
(supplementary material Fig. S1M–R), indicating that they are
not the sumoylation sites. However, the localization of the
isopeptidase USPL1 in CBs (Schulz et al., 2012) suggests that
desumoylation events can occur in these bodies.
Bioinformatic analysis of human SMN with SUMOplot (http://
www.abgent.com/tools) and SUMOsp 2.0 (http://sumosp.
biocuckoo.org) servers revealed the presence of a SUMO
acceptor lysine within a consensus site (F-K119-R-E) with a
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Fig. 1. SMN is a SUMO1 substrate. (A–H) Immunostaining for coilin and snRNPs (A–D), or coilin and SUMO1 (E–H) in MCF7 cells expressing
GFP–SMNwt showing SUMO1-immunoreactive CBs. Scale bar: 15 mm. (I,J) Interactions of both endogenous SMN and GFP–SMNwt with SUMO1 in
co-immunoprecipitation assays (*SMN–SUMO1 complex). (K) Sumoylation assay of the recombinant Myc–SMN protein. (L) Protein sequence of the human
SMN Tudor domain.












high probability for sumoylation. Furthermore, the GPS-SBM
(http://sbm.biocuckoo.org) server identified a SIM consisting of
three consecutive valine residues (V124-V125-V126) flanked by
acidic residues (E121, E134-E135) and putative residues for
phosphorylation (T122, T128, Y127 and Y130), which were
conserved in several mammalian species (Fig. 1L). Given that
such a sequence does not conform exactly to the proposed
canonical SIMs (Song et al., 2004), we call it SIM-like.
Interestingly, both the K119 residue and SIM-like motif are
strategically located in consecutive sequences within the b3-
strand of the SMN Tudor domain (Fig. 1L), which is a crucial
sequence for multiple interactions with several CB proteins
(Selenko et al., 2001; Renvoisé et al., 2006; Tripsianes et al.,
2011).
SMN has a SIM-like sequence that regulates CB assembly and
coilin localization
To determine whether covalent or non-covalent SMN–SUMO1
interactions are involved in CB assembly, the GFP–SMNwt
construct was mutated by replacing lysine 119 for arginine
(GFP-SMN-K119R) or by replacing two or three valine residues
of the SIM-like sequence for the minor hydrophobic alanine
residues (GFP–SMN-V124/125A or GFP–SMN-V124/125/126A)
(Fig. 2A).
Next, we expressed GFP–SMNwt in MCF7 cells previously
depleted from endogenous SMN with a 39-UTR small interfering
RNA (siRNA). The efficiency of the siRNA was confirmed by
immunoblotting (Fig. 2B; supplementary material Fig. S2A). SMN
depletion induced dramatic changes in coilin expression, including
loss of CB and relocalization of coilin within the nucleolus and in
numerous nucleoplasmic microfoci (supplementary material Fig.
S2B,C), as previously reported in HeLa cells (Lemm et al., 2006).
This coilin reorganization is consistent with previous studies
showing nucleolar accumulations of coilin upon the experimental
disruption of CBs (Tapia et al., 2010; Gilder and Hebert, 2011) and
with our recent observation that SMN depletion in human motor
neurons from SMA patients causes CB loss and nucleolar
relocalization of coilin (Tapia et al., 2012).
The expression of the mutant K119R in the SUMO acceptor site
in SMN-depleted cells rescued the normal nuclear phenotype
observed in MCF7 cells transfected with the GFP–SMNwt construct
(Fig. 2C,D), indicating that the lysine K119 residue is not essential
for CB assembly. In contrast, transfections with the SIM-like
mutants were unable to rescue the normal phenotype, which
displayed a dramatic loss of CBs and intranucleolar relocalization of
coilin (Fig. 2E,F). Changes in CB distribution in all transfection
experiments were confirmed by quantitative analysis (Fig. 2G,H;
supplementary material Table S1). Collectively, these results
identified that the SIM-like sequence, but not the K119, plays an
important role in CB assembly. In this context, we consider it
important to investigate whether the CB disruption in SMN SIM-like
mutants could be explained by modifications in the structure of the
Tudor domain or by an inefficient interaction of SMN with SUMO
or other target proteins involved in CB biogenesis.
Loss of hydrophobicity in SMN SIM-like motif reduces its protein–
protein affinity and aggregation capacity
To determine the biophysical properties of the SMN SIM-like
motif, we performed a bioinformatics analysis by designing
theoretical mutations with a loss of hydrophobicity (V124A/
V125A and V124A/V125A/V126A) and with an increase in
hydrophobicity (V124I/V125I). First, to correlate changes in the
hydrophobicity with the aggregation propensity we used the
AGGRESCAN server. Fig. 3A illustrates the localization of two
hydrophobic stretches in the wild-type SMN Tudor domain,
amino acid residues A111–I116 and R120–G129. The algorithm
predicts that the V124A/V125A and V124A/V125A/V126A
mutations dramatically reduce hydrophobicity of the R120–
G129 stretch and cause lower scores for protein aggregation, as
compared with the wild-type or the SMN V124I/V125I mutant
that has higher hydrophobicity (Fig. 3B). Second, the IUPred
server showed that the decrease in hydrophobicity in the SIM-like
mutants conveys a relative propensity to disorder within the SMN
Tudor domain in comparison with both the wild-type and the
mutant V124I/V125I proteins (Fig. 3C) (Conchillo-Solé et al.,
2007). The propensity to disorder of the hydrophobic mutant
proteins might modify the affinity of SMN for its binding targets
(Uversky et al., 2008). Finally, given that the Tudor motif had
been crystallized (Selenko et al., 2001), valine residues 124–126
were localized in its structure (PDB 1G5V). In the predicted
structure of V124A/V125A/V126A, mutant replacement of the
three valine residues for alanine residues did not affect the
structure of the Tudor domain, but surface hydrophobicity was
modified (Fig. 3D). Thus, this mutation probably affects
protein–protein recognition. In fact, whereas nuclear bodies
containing ectopic SMN were present in MCF7 cells expressing
the wild-type or the more hydrophobic SIM-like construct
(Fig. 3E,H,I), these tended to disappear in cells expressing
mutant proteins that had loss of hydrophobicity (Fig. 3F,G,I). In
these latter cells, coilin and Gemin2 colocalized in the few
endogenous CBs (supplementary material Fig. S2G–J).
Interestingly, a fluorescence intensity analysis of nuclear GFP–
SMN proteins revealed that the reduction in hydrophobicity did
not interfere with the nuclear import of mutant SMN SIM-like
proteins (Fig. 3J), suggesting a defective interaction of SMN
with CB-protein partners rather than a defective nuclear import
(Narayanan et al., 2004). In this way, a defect in the targeting of
SMN to CBs is a cardinal feature of SMA motor neurons (Hebert
et al., 2001; Tapia et al., 2012).
The SIM-like domain regulates SMN interactions with spliceosomal
SmD1 and coilin
To determine whether the SIM-like motif is involved in the
protein–protein interactions needed for CB biogenesis we
studied three processes: sumoylation of SMN, interaction of
SMN with components of the snRNP biogenesis pathway, and
SMN–coilin interactions in the molecular assembly of CBs
(Fig. 4A).
Given that the hydrophobic interaction between the SIM of the
target protein and SUMO1 often precedes and enhances covalent
conjugation with SUMO (Kerscher, 2007), we have investigated
whether the SIM-like domain is involved in covalent sumoylation of
the SMN (Fig. 4A). To address this issue, 293T cells were
transfected with GFP, GFP–SMNwt or GFP–SMN-V124/125A
and total lysates were subjected to western blot analysis.
Immunodetection of GFP–SMN-SUMO with anti-SUMO antibody
showed that the lower hydrophobicity in the SIM-like mutant
did not abrogate the SMN–SUMO1 interaction (Fig. 4B). Covalent
sumoylation of GFP–SMNwt and GFP–SMN-V124/125A was
confirmed by co-immunoprecipitation (Fig. 4C). Although our
results indicate that the SIM-like domain is not required
for covalent sumoylation of SMN, we cannot discard that the
free groove of the covalently bound SUMO1 to SMN or that the
SIM-like sequence mediate other molecular interactions.












Regarding the snRNP biogenesis pathway, it is well known
that SMN is involved in the following steps (Fig. 4A): (1) SMN
oligomerization (Lorson et al., 1998; Martin et al., 2012), (2)
SMN interaction with Gemin proteins (Zhang et al., 2011), (3)
SMN binding to the Sm complex proteins of snRNPs, which are
key constituents of spliceosomes (Pellizzoni et al., 2002), and
(4) SMN–coilin interaction in CBs (Hebert et al., 2001)
(Fig. 4A).
Fig. 2. The SMN SIM-like sequence regulates CB assembly. (A) Table of GFP–SMN mutant variants used in this study. (B) Reduction of endogenous SMN
protein levels in SMN-depleted MCF7 cells transfected with the GFP–SMN constructs used here. (C–F) Coilin immunostaining in SMN-depleted cells
transfected with GFP–SMNwt, GFP–SMN-K119R, GFP–SMN-V124/125A and GFP–SMN-V124/125/126A constructs. Scale bar: 10 mm. (G,H) Distribution of
CBs in SMN-depleted MCF7 cells expressing SMNwt and SIM-like mutant proteins. Means6s.d. from three independent experiments (at least 70 cells per
experiment were assayed; ***P,0.001 as compared with control siRNA).












First, we want to determine whether the SIM-like domain is
involved in SMN homo-oligomerization. We performed co-
immunoprecipitation experiments in 293T cells transfected with
GFP, GFP–SMNwt or GFP–SMN-V124/125A. Immunoblotting
for GFP immunoprecipitates with the anti-SMN antibody
demonstrated that wild-type and mutant GFP–SMN proteins
Fig. 3. The hydrophobicity in SMN SIM-like motif correlates with the aggregation propensity. (A,B) The AGGRESCAN server predicts that both V124A/
V125A and the V124A/V125A/V126A mutations reduce the hydrophobicity and aggregation propensity of the SIM-like domain. (C) The IUpred server
predicts that there is a tendency for disorder of SIM-like mutants with decreased hydrophobicity. (D) A PyMOL ribbon representation for the SMN Tudor domain.
On the left, hydrophobic residues of the SIM-like domain are highlighted by a stick representation in orange. In the right panel, V124, V125 and V126 were
replaced by alanine residues (purple sticks) to create the mutant model. (E–H) SIM-like mutants V124A/V125A or V124A/V125A/V126A fail to assemble GFP–
SMN-positive nuclear bodies. Scale bar: 15 mm. (I) Distribution of the nuclear bodies in MCF7 cells transfected with GFP–SMN constructs (n5200 cells per
condition; means6s.d.; ***P,0.001 as compared with controls). (J) Fluorescence intensity analysis of nuclear GFP–SMNwt and mutant variants in MCF7 cells.
(n5100 per condition; means6s.d.; **P,0.01, ***P,0.001 as compared with wild-type or the V124I/V124I mutant).












Fig. 4. The SIM-like domain regulates SMN interactions with SmD1 and coilin. (A) Schematic representation of the putative functions of the SMN SIM-like
domain in snRNP biogenesis and CB assembly. (B,C) Covalent interaction of GFP–SMNwt and GFP–SMN-V124/125A with SUMO1 was detected by western
blotting (B, asterisk) or coimmunoprecipitation (C). (D) 293T cells were transfected with GFP, GFP–SMNwt or GFP–SMN-V124/125A. After GFP
immunoprecipitation from cell lysates, SMN enrichment was monitored by anti-SMN in western blot analysis. (E) 293T cells were transfected with GFP, GFP–
SMNwt or GFP–SMN-V124/125A. After GFP immunoprecipitation from cell lysates, endogenous Gemin2, SmD1 or coilin protein levels were detected by
western blotting. (F–H) Graphs show the average of three independent experiments. ***P,0.001.












interact with similar affinity to endogenous SMN (Fig. 4D),
indicating that the integrity of the SIM-like domain is not
necessary for SMN self-oligomerization.
Second, we investigated whether the SIM-like domain
participates in the assembly of the SMN complex, in which the
SMN oligomer conjugates to eight proteins, Gemin2–Gemin8 and
Unrip. The SMN–Gemin2 interaction is of particular importance
because both proteins form a heterodimer in the core of the SMN
complex, which recognizes spliceosomal Sm proteins (Paushkin
et al., 2002). Co-immunoprecipitation experiments with GFP–
SMNwt and GFP–SMN-V124/125A proteins demonstrated that
although the SIM-like mutation slightly reduced the interaction of
SMN with endogenous Gemin2, this change is not statistically
significant (Fig. 4E,F). These results are consistent with previous
reports suggesting that the SMN motifs responsible for SMN
oligomerization and Gemin2 binding are far from the Tudor
domain (Martin et al., 2012).
Next, we investigated the interaction of the SMN SIM-like
domain with the SmD1 protein of the Sm complex. This complex
contains seven proteins encircled in a single-stranded domain of
snRNA (Fischer et al., 2011). Interestingly, snRNP assembly
requires a direct binding of SMN to the SmD1 protein (Grimm
et al., 2013). Previous studies have demonstrated that the point
mutations Y130C and E134K, which are in residues flanking the
SIM-like cause SMA. Particularly, E134 is essential for the
SMN–SmD1 interaction (Bühler et al., 1999; Selenko et al.,
2001). In this context, our co-immunoprecipitation experiments
showed that the binding of GFP–SMN-V124/125A with the
endogenous SmD1 is reduced more than 5-fold compared with
GFP–SMN-wt (Fig. 4E,G).
Finally, we investigated whether the SMN SIM-like mutation
interferes with the binding of coilin to SMN (Fig. 4A). Previous
studies have shown that the recruitment of SMN and snRNPs to
CBs depends on the direct interaction of SMN with coilin
(Hebert et al., 2001; Tucker et al., 2001). Interestingly, the co-
immunoprecipitation experiment also revealed that the SIM-like
mutation present in GFP–SMN-V124/125A severely impaired its
binding with the endogenous coilin (more than 2-fold compared
with the SMNwt) (Fig. 4E,H). Although previous binding assays
have shown that the C-terminal of coilin interacts with the SMN
Tudor domain (Hebert et al., 2001), our biochemical results
demonstrate that the SIM-like sequence also contributes to
regulating this interaction.
In conclusion, our data demonstrate that the SIM-like sequence of
SMN is essential for CB assembly and also suggest that it is involved
in snRNP biogenesis. We demonstrate that the new SMN mutations
reported here (V124A/V125A and V124A/V125A/V126A) do not
affect the nuclear localization of SMN but disrupt the interaction with
coilin and SmD1 proteins. Given that aberrant splicing is a
biochemical defect in SMA (Zhang et al., 2011), our data add a
significant component to SMA pathophysiology investigation. Further
studies on the SIM-like domain might be an important hot spot for
screening point mutations in SMA patients with heterozygous deletion
of the SMN1 gene.
MATERIALS AND METHODS
Cell culture and transfection assays
UR61, MCF7 and 293T cell lines were cultured as described previously
(Tapia et al., 2012). Transfections with siRNA directed against the
human 39UTR SMN were performed with Lipofectamine-RNAiMAX
(Invitrogen), and cells were assayed 48 h after transfection. For rescue
experiments, human GFP–SMNwt and mutant constructs were
transfected 48 h after siRNA transfection. The GFP–SMNwt and Myc–
SMN constructs used in this study have been described previously
(Sleeman et al., 2003; Pellizzoni et al., 1998).
Mutagenesis
GFP–SMN-binding mutants were constructed by site-directed mutagenesis
by PCR using the QuikChange II mutagenesis kit (Stratagene).
Confocal microscopy and quantification
Endogenous and ectopically expressed SMN, other CB markers and
SUMO were imaged with a Zeiss LSM-510 confocal microscopy system
equipped with a 636 oil objective (1.4NA). See antibodies used in
supplementary material Fig. S1.
Immunoprecipitation
Immunoprecipitation with Sepharose-coupled GFP binder was as
previously described (Rothbauer et al., 2008). For immunoprecipitation
of endogenous protein, lysates were first mixed with rabbit IgG or rabbit
anti-SMN antibody for 2 h at 4 C̊ before addition of protein-A–agarose
for 2 h at 4 C̊.
Western blotting
Proteins transferred from SDS-PAGE gels to polyvinylidene difluoride
membranes were visualized with the Odyssey system (LI-COR
Biotechnology).
Sumoylation assay
For the sumoylation assay, Myc-tagged SMN proteins were in vitro
synthesized using TnT quick coupled transcription/translation system
(Promega) following the manufacturer’s instructions. Recombinant Myc–
SMN proteins were immunoaffinity purified using anti-Myc beads
(Sigma-Aldrich, St. Louis, MO) and verified by SDS-PAGE. For the in
vitro sumoylation assay, the K007 kit (LEA Biotech International) was
used according to the manufacturer’s protocol. Protein sumoylation was
analyzed by SDS-PAGE and western blotting using anti-Myc (Ab1014)
and anti-SUMO1 (21 C7, Zymed) antibodies.
Statistical analysis
Statistical significance was determined by unpaired, two-tailed Student’s
t-tests.
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